Legislation
- Title
- Pharmacists - Biosimilar Biological Products - Substitutions
- Sponsored by
- Senator Conway
- Status
- In the House - Hearing 4/04 at 1:00 p.m.
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Authorizing pharmacists to substitute biosimilar biological products for prescribed biological reference products only under specified circumstances; requiring pharmacists or their designees to give specified notices and record specified information if the pharmacist substitutes an interchangeable biosimilar biological product for a prescribed biological reference product; etc.
Committees
Details
Bill File Type: Regular
Effective Date(s): October 1, 2013
History
Toggle History Dropdown
Documents
Toggle Documents Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
12-101, 12-504, 12-504.1 )
Last Updated: 2/3/2020 2:28 PM